Exhibit E.
----------
JOINT FILING AGREEMENT
The undersigned hereby agree that the Statement on Schedule 13D, dated
January 28, 1997, (the "Schedule 13D"), with respect to the Common Stock, par
value $0.0001 per share, of Alexion Pharmaceuticals, Inc. is, and any amendments
thereto executed by each of us shall be, filed on behalf of each of us pursuant
to and in accordance with the provisions of Rule 13d-1(f) under the Securities
and Exchange Act of 1934, as amended, and that this Agreement shall be included
as an Exhibit to the Schedule 13D and each such amendment. Each of the
undersigned agrees to be responsible for the timely filing of the Schedule 13D
and any amendments thereto, and for the completeness and accuracy of the
information concerning itself contained therein. This Agreement may be executed
in any number of counterparts, all of which taken together shall constitute one
and the same instrument.
IN WITNESS WHEREOF, the undersigned have executed this Agreement as of
the 28th day of January, 1997.
XXXXXX X. XXXXX XXXXX XXXXX
/s/ Xxxxxx X. Xxxxx /s/ Xxxxx Xxxxx
-------------------------- --------------------------
PHARMA/wHEALTH M and I INVESTORS, INC.
By: /s/ Mirko von Restorf By: /s/ Xxxxxx X. Xxxxx
-------------------------- ------------------------
Name: Xxxxx xxx Xxxxxxxx Name: Xxxxxx X. Xxxxx
Title: Chairman Title: President
CADUCEUS CAPITAL, L.P. CADUCEUS CAPITAL MANAGEMENT, INC.
By: /s/ Xxxxxx X. Xxxxx By: /s/ Xxxxxx X. Xxxxx
-------------------------- -----------------------
Name: Xxxxxx X. Xxxxx Name: Xxxxxx X. Xxxxx
Title: Title: President
Exhibit E.
----------
WORLDWIDE HEALTH MEHTA & XXXXX ASSET
SCIENCES PORTFOLIO MANAGEMENT, INC.
By: /s/ Xxxx X. Xxxxxxxx By: /s/ Xxxxxx X. Xxxxx
-------------------------- -----------------------
Name: Xxxx X. Xxxxxxxx Name: Xxxxxx X. Xxxxx
Title: Assistant Secretary Title: President
